Thu, May 7, 2020

Douglas Tsao Reiterated (TXMD) at Strong Buy with Decreased Target to $250 on, May 7th, 2020

Douglas Tsao of HC Wainwright & Co., Reiterated "TherapeuticsMD, Inc." (TXMD) at Strong Buy with Decreased Target from $300 to $250 on, May 7th, 2020.

Douglas has made no other calls on TXMD in the last 4 months.



There is 1 other peer that has a rating on TXMD. Out of the 1 peers that are also analyzing TXMD, 0 agree with Douglas's Rating of Hold.



This is the rating of the analyst that currently disagrees with Douglas


  • Annabel Samimy of "Stifel" Maintained at Strong Buy with Increased Target to $750 on, Thursday, April 16th, 2020


Similar Stocks and Investing Publications